Treatment of MRSA in Urine Culture

Initial Assessment and Management

The Infectious Diseases Society of America recommends assessing for symptoms of urinary tract infection and systemic symptoms to distinguish between asymptomatic bacteriuria, uncomplicated UTI, or complicated UTI with potential bacteremia 1
Obtain blood cultures if systemic symptoms are present to rule out concurrent bacteremia, which would require more aggressive management 1, 2

The American College of Clinical Pharmacy recommends intravenous vancomycin at a dose of 15-20 mg/kg/dose every 8-12 hours for adults or 15 mg/kg/dose every 6 hours for children, with dose adjustment based on renal function and therapeutic drug monitoring 1, 2
Daptomycin is an alternative for patients who cannot tolerate vancomycin, with a recommended dose of 6 mg/kg/dose IV once daily, and some experts recommend higher doses of 8-10 mg/kg/dose for complicated infections 1

Trimethoprim-sulfamethoxazole (TMP-SMX) is recommended at a dose of 1-2 double-strength tablets orally twice daily 2
Linezolid is recommended at a dose of 600 mg orally twice daily, with a cure rate of 90% in skin and soft tissue infections 2

The Infectious Diseases Society of America recommends a treatment duration of 7-14 days for uncomplicated MRSA bacteriuria without systemic symptoms 1, 2
For complicated MRSA bacteriuria or concurrent bacteremia, the recommended treatment duration is 2-4 weeks depending on clinical response and clearance of bacteremia 1

Follow-up urine cultures should be obtained 48-72 hours after initiating therapy to document clearance of infection 1
The Infectious Diseases Society of America recommends evaluating for anatomical abnormalities, retained foreign bodies, or abscesses in cases of recurrent or persistent MRSA UTI 1